Hyperuricemia in Chronic Heart Failure

被引:0
|
作者
Larina, V. N. [1 ]
Bart, B. Ya. [1 ]
Brodsky, M. S. [1 ]
机构
[1] Russian State Med Univ, Moscow 117437, Russia
关键词
hyperuricemia; chronic heart failure; SERUM URIC-ACID; CARDIOVASCULAR-DISEASE; ENDOTHELIAL FUNCTION; XANTHINE-OXIDASE; ALLOPURINOL; LOSARTAN; URATE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Development of hyperuricemia is associated with excessive body mass, insulin resistance, metabolic syndrome, overuse of diuretics, elderly age, and abnormal renal function. Data are accumulated on existence of links between elevated uric acid level and arterial hypertension, diabetes mellitus, ischemic heart disease, and chronic heart failure (CHF). Hyperuricemia has been found in 60% of patients hospitalized because of decompensation of CHF. In CHF isolated hyperuricemia (irrespective of the state of renal function and administration of drugs) appears to be a marker of altered oxidative metabolism characterized by elevation of levels of free radicals which damage cardiomyocytes and vascular endothelium inducing disturbances of myocardial contractility and vasoconstriction. Hyperuricemia associated with insulin resistance, tissue hypoxia, elevated production of cytokines and free radicals can negatively affect cardiovascular system and worsen prognosis in patients with CHF.
引用
收藏
页码:68 / 73
页数:6
相关论文
共 50 条
  • [21] Multicenter Randomized Controlled Trial Between Febuxostat and Allopurinol in Chronic Heart Failure Patients With Hyperuricemia
    Suzuki, Satoshi
    Yoshihisa, Akiomi
    Sato, Akihiko
    Shimizu, Takeshi
    Sato, Takamasa
    Sakamoto, Nobuo
    Nakazato, Kazuhiko
    Tsuda, Tatsunori
    Tsuda, Akihiro
    Goto, Jun
    Ishibashi, Toshiyuki
    Konno, Ichiro
    Yamaguchi, Osamu
    Machii, Hirofumi
    Nozaki, Naoki
    Niizeki, Takeshi
    Miyamoto, Takuya
    Kubota, Isao
    Takeishi, Yasuchika
    CIRCULATION, 2017, 136
  • [22] Cardiac MIBG Imaging Predicts Cardiac Death in Patients With Chronic Heart Failure, Irrespective of Hyperuricemia
    Takahashi, Satoshi
    Yamada, Takahisa
    Morita, Takashi
    Furukawa, Yoshio
    Tamaki, Shunsuke
    Iwasaki, Yusuke
    Kawasaki, Masato
    Kikuchi, Atsushi
    Kondo, Takumi
    Kawai, Tsutomu
    Ishimi, Masashi
    Hakui, Hideyuki
    Ozaki, Tatsuhisa
    Sato, Yoshihiro
    Seo, Masahiro
    Fukunami, Masatake
    CIRCULATION, 2014, 130
  • [23] Hyperuricemia predicts adverse outcomes in patients with heart failure
    Hamaguchi, Sanae
    Furumoto, Tomoo
    Tsuchihashi-Makaya, Miyuki
    Goto, Kazutomo
    Goto, Daisuke
    Yokota, Takashi
    Kinugawa, Shintaro
    Yokoshiki, Hisashi
    Takeshita, Akira
    Tsutsui, Hiroyuki
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 151 (02) : 143 - 147
  • [24] Hyperuricemia and mortality in heart failure: Is it time to change the route?
    Borghi, Claudio
    Cosentino, Eugenio
    Bragagni, Alessio
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 72 : 40 - 41
  • [25] Hyperuricemia and the Risk of Heart Failure: Pathophysiology and Therapeutic Implications
    Si, Ke
    Wei, Chijing
    Xu, Lili
    Zhou, Yue
    Lv, Wenshan
    Dong, Bingzi
    Wang, Zhongchao
    Huang, Yajing
    Wang, Yangang
    Chen, Ying
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [26] Prognostic Significance of Hyperuricemia in Patients With Acute Heart Failure
    Palazzuoli, Alberto
    Ruocco, Gaetano
    Pellegrini, Marco
    Beltrami, Matteo
    Giordano, Nicola
    Nuti, Ranuccio
    McCullough, Peter A.
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (10): : 1616 - 1621
  • [27] Is prognostic impact of hyperuricemia homogenous in patients with heart failure?
    Joho, S.
    Ushijima, R.
    Nakagaito, M.
    Nakamura, M.
    Kinugawa, K.
    EUROPEAN HEART JOURNAL, 2018, 39 : 577 - 577
  • [28] Hyperuricemia as a marker for anaerobic threshold in chronic cardiac failure
    Martínez, A
    Pérez, P
    Ossa, C
    Corbalán, R
    Jalil, J
    Acevedo, PCG
    REVISTA MEDICA DE CHILE, 2001, 129 (05) : 503 - 508
  • [29] The mechanism and the beneficial effect of treatment of hyperuricemia in congestive heart failure
    Ogino, K
    Osaki, H
    Kinugawa, T
    Kato, M
    Kinugasa, Y
    Ishida, K
    Igawa, O
    Hisatome, I
    Shigemasa, C
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (09) : S302 - S302
  • [30] Hyperuricemia in US Population with Heart Failure: Causal or Incidental Bystander?
    Ruocco, Gaetano
    Palazzuoli, Alberto
    CARDIORENAL MEDICINE, 2019, 9 (06) : 341 - 343